Danhof M, de Boer A G, de Groot-van der Vis E, Breimer D D
Pharmacology. 1979;19(4):215-20. doi: 10.1159/000137313.
An assay procedure is described for 3-carboxy-antipyrine in urine using gas chromatography with a support coated open tubular capillary column (Carbowax 20M), a solid injection system and nitrogen selective detection. 3-Carboxy-antipyrine was analyzed after derivatization with diazomethane and using 4-bromo-antipyrine as internal standard. Following extraction of the urine samples with a mixture of organic solvents linear calibration curves were obtained in the concentration range of 1--50 microgram/ml. The precision was established as +/- 5.0% (n = 5), and the lowest measurable concentration was 1 microgram/ml at a signal-to-noise ratio of 10:1. Preliminary results in 5 human volunteers showed that after orl administration of 500 mg antipyrine, 3.3 +/- 0.8% of the dose was excreted as 3-carboxy-antipyrine in 52 hours' urine. The compound was excreted completely in the unconjugated form.
本文描述了一种采用气相色谱法,以涂覆载体的开口管毛细管柱(Carbowax 20M)、固体进样系统和氮选择性检测来测定尿液中3-羧基安替比林的分析方法。3-羧基安替比林经重氮甲烷衍生化后,以4-溴安替比林作为内标进行分析。用有机溶剂混合物萃取尿液样品后,在1-50微克/毫升的浓度范围内获得线性校准曲线。精密度确定为±5.0%(n = 5),在信噪比为10:1时,最低可测浓度为1微克/毫升。5名人类志愿者的初步结果表明,口服500毫克安替比林后,52小时尿液中3-羧基安替比林的排泄量占给药剂量的3.3±0.8%。该化合物以未结合形式完全排泄。